Simple jQuery Dropdowns

Browsing by Author Kanta Subbarao

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
1-Jan-2014African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidatesYumiko Matsuoka; Amorsolo Suguitan; Marlene Orandle; Myeisha Paskel; Kobporn Boonnak; Donald J. Gardner; Friederike Feldmann; Heinz Feldmann; Michael Marino; Hong Jin; George Kemble; Kanta Subbarao; National Institute of Allergy and Infectious Diseases; National Institutes of Health, Bethesda; MedImmune, Inc.; American University of the Caribbean; Mahidol University; FDA Center for Biologics Evaluation and Research; 3-V Biosciences, Inc.
1-Aug-2017Development of clade-specific and broadly reactive live attenuated influenza virus vaccines against rapidly evolving H5 subtype virusesKobporn Boonnak; Yumiko Matsuoka; Weijia Wang; Amorsolo L. Suguitan; Zhongying Chen; Myeisha Paskel; Mariana Baz; Ian Moore; Hong Jin; Kanta Subbarao; National Institute of Allergy and Infectious Diseases; MedImmune, Inc.; Mahidol University; Université Laval; World Health Organization, Australia
1-Jan-2014Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virusChristopher D. O'Donnell; Amber Wright; Leatrice Vogel; Kobporn Boonnak; John J. Treanor; Kanta Subbarao; National Institute of Allergy and Infectious Diseases; University of Rochester Medical Center; National Academy of Sciences; University of Washington, Seattle; Mahidol University
15-Jun-2014Lymphopenia associated with highly virulent H5N1 virus infection due to plasmacytoid dendritic cell-mediated apoptosis of T cellsKobporn Boonnak; Leatrice Vogel; Friederike Feldmann; Heinz Feldmann; Kevin L. Legge; Kanta Subbarao; National Institute of Allergy and Infectious Diseases; National Institutes Allergy and Infectious Diseases, Hamilton; National Institutes of Health, Bethesda; University of Iowa; Mahidol University
1-Jun-2021Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy VolunteersMyron M. Levine; Salim Abdullah; Yaseen M. Arabi; Delese Mimi Darko; Anna P. Durbin; Vicente Estrada; Euzebiusz Jamrozik; Peter G. Kremsner; Rosanna Lagos; Punnee Pitisuttithum; Stanley A. Plotkin; Robert Sauerwein; Sheng Li Shi; Halvor Sommerfelt; Kanta Subbarao; John J. Treanor; Sudhanshu Vrati; Deborah King; Shobana Balasingam; Charlie Weller; Anastazia Older Aguilar; M. Cristina Cassetti; Philip R. Krause; Ana Maria Henao Restrepo; Faculty of Tropical Medicine, Mahidol University; Regional Centre for Biotechnology; Centro para Vacunas en Desarrollo Chile; King Saud bin Abdulaziz University for Health Sciences; Ifakara Health Institute; Universitetet i Bergen; Wuhan Institute of Virology Chinese Academy of Sciences; Universidad Complutense de Madrid; Organisation Mondiale de la Santé; University of Melbourne; University of Rochester Medical Center; Universitätsklinikum und Medizinische Fakultät Tübingen; Bill and Melinda Gates Foundation; Wellcome Trust; Monash University; National Institute of Allergy and Infectious Diseases (NIAID); Radboud Universiteit; University of Maryland School of Medicine; Food and Drug Administration; University of Pennsylvania; Johns Hopkins Bloomberg School of Public Health; WHO RandD Blueprint COVID-19 Vaccines Working Group; Centre de Recherches Médicales de Lambaréné